Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.345 USD | +1.08% | +1.96% | +1.52% |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.52% | 94.26M | |
+69.16% | 62.86B | |
-1.03% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.41% | 26.46B | |
-21.88% | 18.9B | |
+4.48% | 12.67B | |
+24.08% | 12.27B | |
+28.71% | 12.07B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Treasurer and Secretary Effective July 5, 2021